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Abstract
Background: Women with ductal carcinoma in situ (DCIS) report poor patient-clinician communication, and long-
lasting confusion and anxiety about their treatment and prognosis. Research shows that patient-centred care (PCC)
improves patient experience and outcomes. Little is known about the clinician experience of delivering PCC for
DCIS. This study characterized communication challenges faced by clinicians, and interventions they need to
improve PCC for DCIS.
Methods: Purposive and snowball sampling were used to recruit Canadian clinicians by specialty, gender, years of
experience, setting, and geographic location. Qualitative interviews were conducted by telephone. Data were
analyzed using constant comparison. Findings were mapped to a cancer-specific, comprehensive PCC framework to
identify opportunities for improvement.
Results: Clinicians described approaches they used to address the PCC domains of fostering a healing relationship,
exchanging information, and addressing emotions, but do not appear to be addressing the domains of managing
uncertainty, involving women in making decisions, or enabling self-management. However, many clinicians
described challenges or variable practices for all PCC domains but fostering a healing relationship. Clinicians vary in
describing DCIS as cancer based on personal beliefs. When exchanging information, most find it difficult to justify
treatment while assuring women of a good prognosis, and feel frustrated when women remain confused despite
their efforts to explain it. While they recognize confusion and anxiety among women, clinicians said that patient
navigators, social workers, support groups and high-quality information specific to DCIS are lacking. Despite these
challenges, clinicians said they did not need or want communication interventions.
Conclusions: Findings represent currently unmet opportunities by which to help clinicians enhance PCC for DCIS,
and underscore the need for supplemental information and supportive care specific to DCIS. Future research is
needed to develop and test communication interventions that improve PCC for DCIS. If effective and widely
implemented, this may contribute to improved care experiences and outcomes for women diagnosed with and
treated for DCIS.
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Background
Ductal carcinoma in situ (DCIS), which comprises up to
25% of all screen-detected abnormalities, includes a
spectrum of abnormal cell types confined to the breast
ducts with variable natural history, and risk for progres-
sion and recurrence [1–4]. Because there is no test to es-
tablish whether DCIS will progress to invasive breast
cancer, recommended treatment for DCIS is similar to
invasive breast cancer and includes surgery (lumpectomy
or mastectomy) with or without adjuvant radiation or
hormone therapy [5, 6]. Adequately treated DCIS has a
favourable prognosis, with 20-year breast cancer specific
mortality rate of 3.3% (95% CI 3.0 to 3.6) [7]. Therefore,
the goal of treatment is to prevent progression to inva-
sive breast cancer, or DCIS recurrence that may pro-
gress, while also conserving healthy breast tissue and
minimizing unnecessary harm.
Despite the good prognosis, women with DCIS have
long-lasting confusion and anxiety about their diagnosis
and treatment [8–10]. For example, in a cross-sectional
survey of 144 women diagnosed with DCIS in Australia,
many were unsatisfied with information provided and
reported misperceptions of risk; 60.0% incorrectly
thought DCIS would metastasize, only 19.0% knew that
not all women with untreated DCIS would develop inva-
sive cancer, and 43.0% worried about dying from their
disease [11]. Similarly, research found that women with
DCIS have comparable concerns about dying from
breast cancer and experience similar psychosocial dis-
tress as women with invasive breast cancer [12].
In contrast to the numerous studies exploring the ex-
periences of women with DCIS, we found only three
studies that examined how physicians approach DCIS
discussions. When surveyed, 22% of 296 physicians in
England, and 78% of 151 physicians in the United States
reported difficulty explaining DCIS and treatment op-
tions to women [13, 14]. Both studies also found that
communication practices varied across physicians in-
cluding whether DCIS was described as cancer, a par-
ticularly confusing issue for women contributing to
psychosocial distress. More recently, a mixed-methods
study found that variation in DCIS terminology among
surgeons was influenced by seniority and geographical
region within England [15]. These studies were con-
ducted a decade ago and may not reflect current views
or practices, findings may not apply beyond the United
States and England, and survey data did not fully explore
the challenges that physicians experienced or their views
on how to improve DCIS discussions.
Patient-centred care (PCC) offers a promising ap-
proach for optimizing patient health care experiences
and outcomes. PCC is defined as care that informs, edu-
cates, engages and activates patients and their family/
care partners consistent with their clinical needs, life
circumstances, and personal preferences [16]. Consider-
able research shows that PCC has enhanced multiple pa-
tient outcomes across numerous conditions and settings
including improved communication and relationship with
providers, service experience, knowledge, and quality of
life, and reduced anxiety, missed work, readmission rates,
and mortality [17–19]. For example, a randomized con-
trolled trial of communication training for both cancer pa-
tients and physicians increased patient engagement, and
discussion of emotions, prognosis, and treatment choices
(0.34, 95% CI 0.06–0.62, p = 0.02) [20].
PCC is widely advocated [21, 22], and could support
and improve patient-clinician communication about
DCIS. Our recent scoping review of research published
from 1997 to 2016 on DCIS communication found no
studies that implemented or evaluated interventions to fa-
cilitate PCC for DCIS [23]. Hence, research is needed to
generate detailed insight that would inform intervention
development. The purpose of this study was to interview
clinicians who care for women with DCIS, and
characterize challenges that influence DCIS communica-
tion and the type of interventions needed to facilitate
patient-centred discussions. By identifying patient-centred
approaches to support women and/or clinicians that could
be broadly implemented, ultimately this may improve pa-
tient care experiences among women with DCIS, and psy-
chosocial outcomes among DCIS survivors.
Methods
Approach
To gather detailed insight on little-known clinician views
about DCIS communication challenges and supports, we
employed a qualitative research design [24]. Specifically,
we used a basic descriptive qualitative approach [25].
This method does not aim to generate theory; instead, it
elicits straightforward descriptions in the participants’
own words about their views and experiences [26]. We
conducted telephone interviews, which allowed for con-
venient and flexible scheduling with busy clinicians from
various geographical locations across Canada. Rigour
was ensured by complying with the 32-item Consoli-
dated Criteria for Reporting Qualitative Research check-
list [27]. We further enhanced rigour by sampling
participants with various characteristics, using open-
ended questions, exploring responses inductively, and in-
dependently deriving and comparing themes [28, 29].
This study was approved by the University Health Net-
work research ethics board. All participants provided
written informed consent prior to the interview. The
interviewer had no relationship with participants.
Sampling and recruitment
Eligible participants were practicing, English-speaking
clinicians who care for women with DCIS including
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general surgeons, surgical, radiation and medical oncolo-
gists, radiologists, registered nurses and patient naviga-
tors. Clinicians were identified using publicly available
databases and invited to participate by regular mail.
Sampling of surgeons and oncologists was purposive by
specialty, geographical location, hospital setting (aca-
demic, community), years of experience and gender. As
qualitative research collects detailed data from represen-
tative participants, we aimed to interview a minimum of
5 clinicians of each aforementioned specialty who varied
in non-mutually exclusive fashion in other sampling
characteristics, for a minimum total of 30 participants, a
common target in qualitative research, which unlike
quantitative research, seeks to gather detailed informa-
tion from a comparatively small number of participants.
Ultimately, sample size in qualitative research is deter-
mined by informational saturation, meaning new themes
do not emerge with successive interviews, which was
assessed through discussion among the research team.
We mailed 891 recruitment packages on March 10, 2017
and reminder packages on May 19, 2017. Snowball sam-
pling, whereby interviewed participants referred us to
other potential participants, [30] was used to recruit ra-
diologists, breast cancer nurses and patient navigators.
We contacted individuals who returned signed consent
forms to schedule an interview.
Data collection
BBN conducted telephone interviews between April 25,
2017 and August 20, 2017. BBN conducted telephone in-
terviews with consenting participants between April 25,
2017 and August 20, 2017. Interview questions were in-
formed by elements that comprise PCC such as patient-
provider communication and patient involvement in
decision-making, but kept purposefully broad and open-
ended to avoid leading or biasing responses [31]. The
interview guide was reviewed by all research team mem-
bers, which included 7 breast cancer surgeons, prior to
first use and again after review of the first 4 interview
transcripts to improve wording and flow of questions. At
the outset of each interview, clinicians were informed
that the purpose was to understand how to achieve PCC
for DCIS. PCC was defined to them as care that informs,
educates, engages and activates patients consistent with
their needs and values [16]. Clinicians were then asked
about their approach for communicating with women
about DCIS diagnosis, treatment and follow-up; barriers
of communication; and recommendations for strategies,
interventions or tools that could improve PCC for DCIS.
Data analysis
BBN and ARG independently analyzed the first four
transcripts, and compared and discussed analysis to
jointly generate a preliminary codebook of themes and
exemplar quotes. This was shared with the research
team, who provided feedback on the codebook. With the
guidance of ARG, BBN analyzed all remaining tran-
scripts concurrent with data collection using constant
comparison [32]. First, we extracted and categorized all
data from each transcript by theme (level one), then
merged and separated themes (level two) [33]. Quotes
were organized by theme, and clinician specialty and
province to identify similarities and differences. The re-
search team reviewed themes and exemplar quotes on
two occasions and provided feedback.
To generate a thorough understanding of how DCIS
discussions could be improved, we mapped themes to a
PCC framework developed by McCormack et al. com-
prised of 6 domains: 1) facilitating healing relationships,
2) exchanging information, 3) responding to patients’
emotions, 4) managing uncertainty, 5) making decisions,
and 6) enabling patient self-management [34]. We chose
the McCormack PCC framework because it was rigor-
ously developed; informed by multiple rounds of input
from patients and clinicians, and thus represents what
patients and clinician consider ideal; more comprehen-
sive of the components of PCC compared with several
other PCC frameworks [35, 36], and specific to cancer
unlike other PCC frameworks. Thus, it represents an
ideal against which to compare clinician-reported DCIS
discussion practices and challenges. Mapping of commu-
nication practices and challenges to the framework iden-
tified whether and how clinicians addressed PCC,
thereby identifying specific gaps or inconsistences, which
represent opportunities for improving PCC for DCIS. .
Results
Participants
Of the 891 clinicians invited to participate, 838 did not re-
spond. Among the 53 that responded, 17 were not eligible.
We obtained consent from 36 clinicians. An additional 12
clinicians recruited via snowball sampling consented to
participate in this study. Of the 48 clinicians that con-
sented, we were unable to schedule an interview with 2. In
total, 46 clinicians were interviewed (Table 1).
Themes by PCC domain
Data organized by theme and participant characteristics
is available in Additional file 1 Themes are described
here by PCC domain, [34] and summarized along with
exemplar quotes in Table 2.
Fostering a healing relationship
Building rapport Clinicians said that, to achieve PCC,
they established rapport with women by exhibiting pa-
tience and ensuring women know they are listening, and
by exchanging pleasantries as a way of getting to know
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the patient. To convey these characteristics, clinicians
said they sat at the same level, directly across or beside
patients, and made eye contact throughout discussions.
They also made a point of asking women questions
about themselves before discussing clinical issues.
Exchanging information
Label for DCIS Clinicians varied in whether they de-
scribed DCIS as a form of cancer. Terms used appeared
to be influenced by personal beliefs about whether DCIS
was distinct from, or a precursor to invasive breast can-
cer. Many clinicians considered the potentially benign
behaviour of DCIS to be uniquely different than invasive
breast cancer and described DCIS using terms such as
‘abnormal cells’ or ‘something between normal and can-
cer’. Clinicians who themselves viewed DCIS as distinct
from cancer said they spent time with women to elimin-
ate confusion by distinguishing DCIS from invasive car-
cinoma. They also purposely avoided using the word
‘cancer’ when describing DCIS. Alternatively, several cli-
nicians believed that, although DCIS is contained within
the breast ducts, it is still a form of cancer, and
employed terms such as ‘early stage breast cancer’ and
‘stage-0 breast cancer’ to describe DCIS.
Achieving patient understanding Clinicians said they
invested considerable time in explaining DCIS, some-
times over multiple appointments, but many patients
remained confused about their diagnosis even after
treatment, which was a source of frustration for
clinicians.
Justifying treatment despite good prognosis Clinicians
said it was challenging for them to justify treatment, par-
ticularly when mastectomy was recommended, while at
the same time assuring women of a good prognosis.
They said this further added to confusion among
women, and their own frustration.
Providing supplemental information Many clinicians
said they referred women to web sites to acquire supple-
mental information about their diagnosis and treatment;
however, they said such resources were inconsistent in
quality and readability. Others said they wanted to pro-
vide women with more information but were unaware of
high quality, up-to-date Internet resources for DCIS.
Most clinicians said that, in the absence of well-
developed information or communication tools for
DCIS, they used self-written or self-drawn notes or dia-
grams to facilitate discussions with women.
Recognizing and responding to emotions
Emphasizing good prognosis While clinicians recog-
nized that women with DCIS are often emotional and
apprehensive during appointments, few described strat-
egies for addressing emotions. Those who did said they
attempted to alleviate concerns by emphasizing a good
prognosis associated with DCIS.
Referring to supportive care Instead of directly offering
emotional support, a few clinicians referred women to
patient navigators or social workers for further informa-
tion and support. Doing so allowed them to focus lim-
ited time on explaining important clinical issues,
knowing that others would address women’s emotions
and concerns. However, most clinicians said they did
not have access to navigators or social workers for
women with DCIS, or referrals were prioritized for
women with invasive breast cancer.
Managing uncertainty
Describing uncertainty Few clinicians said they dis-
cussed the likelihood of untreated DCIS progressing to
invasive cancer with patients. Those who did employed
vague terms such as likely or unlikely. None employed
statistics or scientific evidence as the basis for
discussion.
Table 1 Participant characteristics
Characteristic n (% of 46)
Specialty
General Surgeon 9 (19.5)
Surgical Oncologist 10 (21.7)
Radiation Oncologist 12 (26.1)
Medical Oncologist 4 (8.7)
Radiologist 5 (10.8)
Registered nurse/ patient navigator 6 (13.0)
Province
British Columbia 12 (26.1)
Alberta 2 (4.3)
Manitoba 3 (6.5)
Ontario 21 (45.6)
Nova Scotia 2 (4.3)
Newfoundland 6 (13.0)
Hospital Setting
Academic 39 (84.7)
Community 7 (15.2)
Self-reported years of practice
< 10 years 28 (60.8)
≥ 10 years 18 (39.1)
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Table 2 Themes and exemplar quotes by PCC domain [34]
PCC domains Themes Exemplar quotes
Fostering healing relationship Building rapport You have to you know take the time to get to
know the patient well enough to be able to
tailor your approach to them. (06 gen surg)
You have to have the ability as a physician to
say, you have all the time you need and I’m
here, I always sit down with the patient and
give them the correct idea that I’m listening,
that I do have time. (05 surg onc)
Exchanging information Label for DCIS Some people talk about DCIS as being a
pre-cancer and patients often come in from
the surgeons saying that, but I don’t agree with
that particular term. So, if that’s the case I clarify
that it is breast cancer, but it’s very early
(04 rad onc)
Achieving patient understanding The main barrier honestly for the most part is a
patient just having the capacity to understand
the notion of a non-invasive breast cancer and
the potential for it to develop into an invasive
breast cancer and that it’s not currently a threat;
patients have a hard time wrapping their head
around that notion. (07 rad onc)
I see my patients at 6-month follow-up following
surgery … and when I see them again, sometimes
patients are still asking me whether or not they
actually had cancer or whether it was DCIS or
not. (04 gen sx)
You end up spending a lot of time explaining to
them the difference between DCIS and invasive
breast cancer because they don’t necessarily
understand that often when they come. They
know they have breast cancer and that’s all they
understand. (04 med onc)
Justifying treatment despite good prognosis They find it harder to understand why they need
a mastectomy for pre-invasive disease … it’s not
that serious but you need a mastectomy. That
can be a difficult discussion (03 surg onc)
Providing supplemental information I have my own personal website which has a
whole bunch of websites on it. So I kind of refer
them to that to look at if they’re of that … wanting
more information. So like I said, I have a personal
website. It has lists of places you can go. Like the
Cancer Society and the NIH and places they can
search for reputable information (01 gen surg)
I refer patients to information from randomized
trials because with DCIS there are many randomized
trials; and very consistent information from the
randomized trials. So I like to use that information
(04 rad onc)
If they want more information … I’m not sure
where or who I’d send them too? if they have
questions along those lines, like someone else ends
up dealing with them more than me. (10 surg onc)
I’ll often times draw a sketch or show
diagrammatically you know how … how for instance
DCIS hasn’t invaded through base membrane. So
I draw a picture of what a milk duct looks like and
show how cancer cells populate and multiply.
(05 gen surg)
Addressing Emotions Emphasizing good prognosis I usually try to explain to the patients that it represents
the best form of breast cancer if they were ever going
to get problem of this nature. (05 gen surg)
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Making decisions
Involving women in decision making When asked
about their approach to involving women in decision-
making, clinicians instead described the treatment op-
tions they offered to women. Many said they first de-
scribed all available treatment options with patients and
then recommended one option. Others said they men-
tioned and recommended only one treatment option as
a way of preventing women from choosing mastectomy
based on anxiety or fear in instances where lumpectomy
was appropriate.
Enabling self-management
Paucity of DCIS-specific resources and support Clini-
cians said that despite wanting to help women access
self-care advice or support, they were unaware of such
resources. They emphasized that information tools such
as pamphlets or web sites, or services offered by patient
navigators or support group focused on invasive breast
cancer or offered little information specific to DCIS, and
were therefore not helpful for women with DCIS.
Challenges or variability in PCC for DCIS
Clinicians described approaches they used to address the
PCC domains of fostering a healing relationship, exchan-
ging information, and addressing emotions. However,
many clinicians described challenges or variable prac-
tices for all PCC domains but fostering a healing rela-
tionship (Table 3). Clinicians vary in describing DCIS as
cancer. When exchanging information, most find it diffi-
cult to justify treatment while assuring women of a good
prognosis, and feel frustrated when women remain
Table 2 Themes and exemplar quotes by PCC domain [34] (Continued)
PCC domains Themes Exemplar quotes
Referring to supportive care These are high maintenance emotional needs
patients. So having somebody that they can
access after the consultation is over just
alleviates a lot of their psychological
consternation. (09 surg onc)
Managing Uncertainty Describing uncertainty I tell them that not all ductal carcinoma in
situ will progress to cancer. We don’t know
exactly which ones will and which ones
won’t. (03 gen surg)
The surgery is more as a precaution to prevent
further development of invasive disease but
more also to make sure that that’s all that
there is there. (07 surg onc)
Making Decisions Involving women in decision making I make sure I know before I go in with the
patient whether or not it is amenable to do
breast conserving surgery. I’ll make sure they
have no contraindications of radiation … then
I can present to them the options. But I don’t
want to present options that are inappropriate.
Then it’s at the patient choice, which they
prefer. (08 surg onc)
Some women choose to have a mastectomy
for this condition but I certainly make it very
clear that for that woman that is not necessary
and it could be completely addressed without
a mastectomy with a much lesser surgery, less
invasive, fewer complications, etc., and then I
would encourage that. (09 surg onc)
If the area looks readily resectable I don’t even
mention the word mastectomy. I just say we’re
gonna, we’ll get this area out. (04 surg onc)
Enabling Self-Management Paucity of DCIS-specific resources and support I don’t think there’s anything that’s specific to
DCIS. A lot of it is kind of it is around the surgery
and what to expect at the time of surgery and if
they need a wire localization procedure. What
that involves and that kind of stuff.. (02 surg onc)
I don’t think there are ones [support groups] for
DCIS specifically. I think they’re all breast … that’s
the problem, breast cancer patients. So these
people are going to support groups with cancer
people which is not ideally the best way. (07 surg onc)
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confused despite their efforts to explain it. Even though
they recognize confusion and anxiety, clinicians said that
resources specific to DCIS that would address emotions
such as patient navigators, social workers, support
groups or high-quality information are lacking. Clini-
cians do not appear to be managing uncertainty, involv-
ing women in making decisions, or enabling self-
management.
Interventions to support PCC for DCIS
Despite the aforementioned challenges, when asked
about interventions to support patient-centred discus-
sions about DCIS, clinicians said they did not need or
would not use training or communication tools because
they believed their current approach to communication
was sufficient.
I’m not sure how useful that would be for me specific-
ally … I’ve got a pretty refined process that I probably
even if something was really great and available I’d prob-
ably you know … not a tool I’d start using. Over 30-
years evolved approach that I find usually works. So I
probably wouldn’t personally find additional tools devel-
opment helpful (01 rad onc).
I can’t think of where it would be helpful for me or
haven’t had any patient’s articulate sort of a disappoint-
ment or a need. I don’t know, I don’t see patients as feel-
ing as lost as invasive patients in terms of wishing they
had the support group or. So I don’t know (08 surg
onc).
I haven’t really had patients say, you know I really
don’t know what I’m doing or what this is about … I
don’t know that there’s a need for something extra spe-
cifically on communication around DCIS (03 surg onc).
Discussion
By comparing self-reported communication practices
against a cancer-specific, comprehensive PCC frame-
work [34], this study identified that many clinicians refer
to DCIS as cancer, and experience difficulty and frustra-
tion in describing DCIS and justifying the need for
Table 3 Summary of challenges and variability in PCC for DCIS
PCC domain Approaches Challenges or Variability
Fostering Healing
Relationships
• Exhibit patience –
• Affirm they are listening
• Exchange pleasantries
• Sit at same level
• Make eye contact
Exchanging information • Distinguish DCIS from invasive cancer • Clinicians differed in whether they believed
DCIS was cancer; as a result, terms used to
describe DCIS also differed: ‘abnormal cells’
versus ‘early stage breast cancer’
• Avoid using the word ‘cancer’
• Spend time explaining DCIS, sometimes over multiple appointments • Frustrating when patients remain confused
about DCIS despite their efforts to explain it
• Difficult to justify treatment while also
assuring women of a good prognosis; this
was frustrating because they knew it further
confused women
• Use self-drawn notes or diagrams in additional to verbal information
• Internet information of poor quality; unaware
of good quality Internet information on DCIS
• Refer women to web sites for supplemental information
Addressing Emotions • Alleviate concerns by emphasizing a good prognosis • Recognize that women with DCIS experience
anxiety and concerns but do not directly
address emotions• Refer women to patient navigators, social workers for information
and emotional support
• Lack access to patient navigators or social
workers
Managing Uncertainty – • Uncertainty not defined or explained in brief,
vague terms (i.e. unlikely)
• None shared statistics or scientific evidence
Making Decisions – • Describe options but recommend one
• Describe and recommend only one option
Enabling Self-
Management
– • Self-care advice or support specific to invasive
breast cancer
• Unaware of DCIS-specific self-management
resources
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treatment in a way that is understood by patients. While
they recognize that women experience confusion and
anxiety, they are unable to offer supplemental help be-
cause information, patient navigators and support
groups for DCIS are not available. Despite these issues,
clinicians said they did not need or would not use com-
munication tools or training to support or improve PCC
for DCIS.
Clinicians in our study and elsewhere [13, 14] used in-
consistent and conflicting terminology to describe DCIS.
The present study provides additional insight regarding
the basis of this variation; use of labels may depend on
ones’ interpretation of DCIS as either unique from or
similar to breast cancer. Referring to DCIS as cancer
contributes to patient confusion, anxiety, and distress,
leading to reduced health-related quality of life and
undermining informed decision-making [11, 37, 38].
Others have advocated that more nuanced nomenclature
for DCIS be developed [39]. Research is needed to ex-
plore the benefits and harms of various labels for DCIS
through input from women and clinicians to optimize
language for DCIS. Greater clarity and consistency in
language used to describe DCIS may help clinicians
when discussing DCIS and improve the patient
experience.
Clinicians in our study who described communication
challenges and lack of high-quality information tools
said they would not benefit from DCIS communication
tools.. Decision aids can support patients in shared
decision-making by eliciting preferences about treatment
options and associated outcomes, but analysis of 21 deci-
sion aids for women with early-stage breast cancer re-
vealed that many failed to comply with widely-used
decision aid standards; offer data on outcome probabil-
ities, information essential to decision-making; or offer
guidance on how to elicit patient preferences [40]. Fur-
thermore, a cohort study found that most patients given
a self-administered decision aid reviewed the informa-
tion, but few made notes or answered questions as
prompted by the decision aid, or shared that information
with their doctors [41]. Shared decision-making consti-
tutes only one of six domains in the PCC framework,
which may explain the limited uptake. Further research
is needed to understand what type of communication
aid would better support patient-centred discussions
about DCIS.
Participating clinicians also said they would not benefit
from training to improve communication about DCIS. Re-
search in both chronic conditions and oncology suggests
that physician communication training can change behav-
iour and improve patient outcomes. For example, a ran-
domized controlled trial found that training interventions
targeted to both oncologists and cancer patients signifi-
cantly improved patient-provider communication [20].
Similarly, a Cochrane systematic review found that PCC
training for clinicians transferred and improved communi-
cation skills among clinicians, resulting in greater engage-
ment of patients in discussions and decision-making [42].
In particular, the review found that short-term training (<
10 h) was as successful as lengthier training, which may
encourage clinicians to participate [43]. Further research
is needed to develop and evaluate training aimed at pa-
tients and/or clinicians that could structure and improve
patient-clinician communication by more fully addressing
PCC domains and sub-domains. A Cochrane systematic
review of interventions to support PCC based on 43 ran-
domized controlled trials found that educational material
showed greater benefit in patient behaviour, satisfaction,
and outcomes, and on the communication process when
aimed at both patients and clinicians rather than targeting
one group only, an approach that may overcome clinician
reluctance by empowering patients to be better prepared
for and take part in DCIS discussions [42].
Similar to previous research [11], clinicians in the
present study reported that women with DCIS are often
confused and would benefit from having access to pa-
tient navigators (PNs), however, PNs were not always
available to women with DCIS. The role of PNs may
provide patients and physicians with support to improve
patient care experiences. The navigation role provides a
measure of security and familiarity through continuity of
care and integrates multiple areas of care coordination,
including streamlining medical appointments, providing
education and assisting with access to financial services
and psychological support throughout and following
treatment [44, 45]. In cancer care, research shows that
patients who had access to PNs reported fewer problems
with care and improved delivery of PCC [46, 47]. There
are several barriers to implementation of PNs, including
availability of trained PNs, distribution of PNs across
rural or remote regions, and health care costs associated
with use of PNs. Although PNs have traditionally been
nurses, they can also be social workers, volunteers or
previous patients [48]. Training for PNs is not yet regu-
lated or required in some jurisdictions; however, PN
training developed by the National Cancer Institute [49]
was designed for individuals with no prior health care
experience and can be delivered over a 3-day training
period [48]. Thus, strategies are available to increase the
number of trained PNs over a short training period. Be-
cause PNs may be scarce in rural or remote regions, fu-
ture research should investigate the value of access to
PNs by telephone or an online service for women with
DCIS [50, 51].
This study was the first to thoroughly explore the
communication practices and perceptions of clinicians
who care for women with DCIS. We employed rigorous
methods, [24, 25, 28, 29] and adhered to qualitative
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research reporting standards [27]. Other strengths in-
clude the diversity of participants (geographic region,
specialty, years in practice, setting), and achieving infor-
mational saturation, which enhances transferability of
the findings. Members of our research team included
practicing clinicians who care for women with DCIS;
they independently analyzed and interpreted study find-
ings, offering critical, real-world feedback to enhance
insight and recommendations. Some limitations of the
present study must be noted. Although we invited many
clinicians with various characteristics, a small proportion
responded as is common in qualitative research; thus,
there may be potential for responder bias, meaning that
clinicians who were especially interested in DCIS or
PCC agreed to be interviewed, which may have influ-
enced responses. Despite our recruitment efforts, only 7
of 46 participating clinicians practiced in non-academic
facilities, so the views and experiences of academic clini-
cians represented the majority of our findings. Given
that all participants practiced in Canada, the findings
may not be relevant elsewhere. The McCormack et al.
PCC framework is not necessarily a “gold standard”, [34]
but as the most comprehensive PCC framework reflect-
ing the priorities of cancer patients, it offered a basis for
further interpreting study findings. While this article did
not compare or correlate clinician findings with the
views of women with DCIS, we have conducted focus
groups with DCIS survivors and will report that data
elsewhere.
Conclusion
By interviewing clinicians who care for women with
DCIS and comparing their self-reported practices to a
comprehensive, cancer-specific PCC framework, this
study identified numerous frustrating communication
challenges experienced by clinicians and variability in
communication practices across clinicians. Although cli-
nicians said they did not need or want communication
interventions, the findings represent currently-unmet
opportunities by which to help clinicians enhance PCC
for DCIS including exchanging information, managing
uncertainty, recognizing and responding to emotions,
making decisions, and enabling self-management. Find-
ings also underscore the need for supplemental informa-
tion and supportive care specific to DCIS.
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